Kinnate Biopharma (KNTE) Stock Highlights

2.65 | +0%

2024-12-21 06:43:07

Kinnate Biopharma Inc a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers. The companys product candidate is KIN-2787, which is a Rapidly Accelerated Fibrosarcoma (RAF) inhibitor it is developing for the treatment of patients with lung cancer, melanoma and other solid tumors. Its KIN003 program is evaluating Fibroblast Growth Factor Receptors (FGFR) inhibitor candidates for the treatment of patients with intrahepatic cholangiocarcinoma (ICC), a cancer of the bile ducts in the liver, and urothelial carcinoma (UC), a cancer of the bladder lining.

Statistics

Range Today

2.65 2.65

Volume Today 0

Range 1 Year

1.04 7.18

Volume 1 Year 155.98M

Range 3 Year

1.04 32.35

Volume 3 Year 230.68M

Range 10 Year

1.04 48.75

Volume 10 Year 253.94M

Highlights

Market Capitalization 124.99M (small)

Floating Shares 22.68M

Current Price 2.65

Price To Earnings 0

Price To Book 0.72

Earnings Per Share -2.78

Payout Ratio 0%

Performance

Latest 0%

1 Month +2.71%

3 Months +8.16%

6 Months +92.03%

1 Year -57.87%

3 Years -91.56%

5 Years -93.38%

10 Years -93.38%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.